NYSE : BLCO
Bausch + Lomb Corporation — Key statistics
Healthcare · Medical Instruments & Supplies · Canada
Last price 20.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.29B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.15B |
| Enterprise Value | 11.73B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 357.50M |
| Shares Outstanding | 357.50M |
| Shares Change (YoY) | +0.80% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 0.18% |
| Owned by Institutions (%) | 10.55% |
| Float | 46.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 16.91 |
| PS Ratio | 1.32 |
| Forward PS | 1.24 |
| PB Ratio | 1.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.37 |
| P/OCF Ratio | 12.91 |
| PEG Ratio | 0.42 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.17 |
| EV / EBITDA | 12.84 |
| EV / EBIT | 23.00 |
| EV / FCF | 46.56 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.56 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 5.21 |
| Debt / FCF | 20.22 |
| Interest Coverage | 1.33 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -1.58% |
| Return on Assets (ROA) | 2.29% |
| Return on Invested Capital (ROIC) | 4.58% |
| Return on Capital Employed (ROCE) | 4.25% |
| Weighted Average Cost of Capital (WACC) | 6.75% |
| Revenue Per Employee | $416,769 |
| Profits Per Employee | -$8,538 |
| Employee Count | 13,000 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.02 |
Taxes
| Measure | Value |
|---|
| Income Tax | 99.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +29.28% |
| 50-Day Moving Average | 17.35 |
| 200-Day Moving Average | 16.67 |
| Relative Strength Index (RSI) | 73.85 |
| Average Volume (20 Days) | 957,847 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.54M |
| Short Previous Month | 3.16M |
| Short % of Shares Out | 0.71% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 5.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.42B |
| Gross Profit | 3.39B |
| Operating Income | 510.00M |
| Pretax Income | -4.00M |
| Net Income | -111.00M |
| EBITDA | 914.00M |
| EBIT | 510.00M |
| Loss Per Share | -$0.31 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 513.00M |
| Total Debt | 5.10B |
| Net Cash | -4.58B |
| Net Cash Per Share | -$12.82 |
| Equity (Book Value) | 6.51B |
| Book Value Per Share | 18.02 |
| Working Capital | 1.10B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 554.00M |
| Capital Expenditures | -302.00M |
| Depreciation & Amortization | 404.00M |
| Net Borrowing | 146.00M |
| Free Cash Flow | 252.00M |
| FCF Per Share | $0.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 62.55% |
| Operating Margin | 9.41% |
| Pretax Margin | -0.07% |
| Profit Margin | -2.05% |
| EBITDA Margin | 16.87% |
| EBIT Margin | 9.41% |
| FCF Margin | 4.65% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.80% |
| Shareholder Yield | -0.80% |
| Earnings Yield | -1.57% |
| FCF Yield | 3.52% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $21.64 |
| Price Target Difference | 8.20% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 6.41% |
| EPS Growth Forecast (3Y) | 43.50% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.97 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |